Dronedarone in High-Risk Permanent Atrial Fibrillation

Stuart J. Connolly, A. John Camm, Jonathan L. Halperin, Campbell Joyner, Marco Alings, John Amerena, Dan Atar, Alvaro Avezum, Per Blomstroem, Martin Borggrefe, Andrzej Budaj, Shih-Ann Chen, Chi Keong Ching, Patrick Commerford, Antonio Dans, Jean-Marc Davy, Etienne Delacretaz, Giuseppe Di Pasquale, Rafael Diaz, Paul DorianGreg Flaker, Sergey Golitsyn, Antonio Gonzalez-Hermosillo, Christopher B. Granger, Hein Heidbuechel, Josef Kautzner, June Soo Kim, Fernando Lanas, Basil S. Lewis, Jose L. Merino, Carlos Morillo, Jan Murin, Calambur Narasimhan, Ernesto Paolasso, Alexander Parkhomenko, Nicholas S. Peters, Kui-Hian Sim, Martin K. Stiles, Supachai Tanomsup, Lauri Toivonen, Janos Tomcsanyi, Christian Torp-Pedersen, Hung-Fat Tse, Panos Vardas, Dragos Vinereanu, Denis Xavier, Jun Zhu, Jun-Ren Zhu, Lydie Baret-Cormel, Estelle Weinling, PALLAS Investigators

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalNew England Journal of Medicine
Volume365
Pages (from-to)2268-2276
Number of pages9
ISSN0028-4793
DOIs
Publication statusPublished - 2011
MoE publication typeA1 Journal article-refereed

Fields of Science

  • AMIODARONE-LIKE AGENT
  • HEART-FAILURE
  • MYOCARDIAL-INFARCTION
  • ANTIARRHYTHMIC AGENTS
  • FOLLOW-UP
  • SR-33589
  • ADRENOCEPTOR
  • ARRHYTHMIAS
  • MORTALITY
  • 3121 General medicine, internal medicine and other clinical medicine

Cite this